Clinical applications of fusion imaging in oncology

A. M. Scott; H. Macapinlac; J. J. Zhang; H. Kalaigian; M. C. Graham; C. R. Divgi; G. Sgouros; S. J. Goldsmith; S. M. Larson

doi:10.1016/0969-8051(94)90049-3

Clinical applications of fusion imaging in oncology

A. M. Scott, H. Macapinlac, J. J. Zhang, H. Kalaigian, M. C. Graham, C. R. Divgi, G. Sgouros, S. J. Goldsmith, S. M. Larson

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Abstract

Recent developments in tumor imaging, made possible by advances in instrumentation and radiopharmaceuticals, has led to an increasing need for accurate anatomic correlation of single photon emission computed tomography (SPECT) and positron emission tomography (PET) images. Fusion imaging permits the functional strengths of SPECT and PET to be combined with the anatomic resolution of computed tomography (CT) and magnetic resonance imaging (MRI). Clinical applications of fusion imaging include the evaluation of brain tumors, lymphoma, hepatic lesions and monoclonal antibody studies. The continued development of these techniques will eventually allow fusion imaging to become a routine part of nuclear medicine practice.

Original language	English (US)
Pages (from-to)	775-784
Number of pages	10
Journal	Nuclear Medicine and Biology
Volume	21
Issue number	5
DOIs	https://doi.org/10.1016/0969-8051(94)90049-3
State	Published - Jul 1994
Externally published	Yes

ASJC Scopus subject areas

Molecular Medicine
Radiology Nuclear Medicine and imaging
Cancer Research

Access to Document

10.1016/0969-8051(94)90049-3

Cite this

@article{9593c8f0a0ae4d7cbb026f61d3d88848,

title = "Clinical applications of fusion imaging in oncology",

abstract = "Recent developments in tumor imaging, made possible by advances in instrumentation and radiopharmaceuticals, has led to an increasing need for accurate anatomic correlation of single photon emission computed tomography (SPECT) and positron emission tomography (PET) images. Fusion imaging permits the functional strengths of SPECT and PET to be combined with the anatomic resolution of computed tomography (CT) and magnetic resonance imaging (MRI). Clinical applications of fusion imaging include the evaluation of brain tumors, lymphoma, hepatic lesions and monoclonal antibody studies. The continued development of these techniques will eventually allow fusion imaging to become a routine part of nuclear medicine practice.",

author = "Scott, {A. M.} and H. Macapinlac and Zhang, {J. J.} and H. Kalaigian and Graham, {M. C.} and Divgi, {C. R.} and G. Sgouros and Goldsmith, {S. J.} and Larson, {S. M.}",

year = "1994",

month = jul,

doi = "10.1016/0969-8051(94)90049-3",

language = "English (US)",

volume = "21",

pages = "775--784",

journal = "Nuclear Medicine and Biology",

issn = "0969-8051",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Clinical applications of fusion imaging in oncology

AU - Scott, A. M.

AU - Macapinlac, H.

AU - Zhang, J. J.

AU - Kalaigian, H.

AU - Graham, M. C.

AU - Divgi, C. R.

AU - Sgouros, G.

AU - Goldsmith, S. J.

AU - Larson, S. M.

PY - 1994/7

Y1 - 1994/7

N2 - Recent developments in tumor imaging, made possible by advances in instrumentation and radiopharmaceuticals, has led to an increasing need for accurate anatomic correlation of single photon emission computed tomography (SPECT) and positron emission tomography (PET) images. Fusion imaging permits the functional strengths of SPECT and PET to be combined with the anatomic resolution of computed tomography (CT) and magnetic resonance imaging (MRI). Clinical applications of fusion imaging include the evaluation of brain tumors, lymphoma, hepatic lesions and monoclonal antibody studies. The continued development of these techniques will eventually allow fusion imaging to become a routine part of nuclear medicine practice.

AB - Recent developments in tumor imaging, made possible by advances in instrumentation and radiopharmaceuticals, has led to an increasing need for accurate anatomic correlation of single photon emission computed tomography (SPECT) and positron emission tomography (PET) images. Fusion imaging permits the functional strengths of SPECT and PET to be combined with the anatomic resolution of computed tomography (CT) and magnetic resonance imaging (MRI). Clinical applications of fusion imaging include the evaluation of brain tumors, lymphoma, hepatic lesions and monoclonal antibody studies. The continued development of these techniques will eventually allow fusion imaging to become a routine part of nuclear medicine practice.

UR - http://www.scopus.com/inward/record.url?scp=0028338372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028338372&partnerID=8YFLogxK

U2 - 10.1016/0969-8051(94)90049-3

DO - 10.1016/0969-8051(94)90049-3

M3 - Article

C2 - 9241654

AN - SCOPUS:0028338372

SN - 0969-8051

VL - 21

SP - 775

EP - 784

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

IS - 5

ER -

Clinical applications of fusion imaging in oncology

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this